We rank companies based on fund manager, research analyst and news sentiment
AWH stock icon

Aspira Women's Health
AWH

$3.49
1.13%
 

About: Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Employees: 64

0
Funds holding %
of 6,474 funds
Analysts bullish %
0
News positive %
of 4 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

1.27% less ownership

Funds ownership: 6.45% [Q3] → 5.18% (-1.27%) [Q4]

4% less funds holding

Funds holding: 24 [Q3] → 23 (-1) [Q4]

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

38% less capital invested

Capital invested by funds: $3.53M [Q3] → $2.19M (-$1.34M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$3.3
5%
downside
Avg. target
$3.3
5%
downside
High target
$3.3
5%
downside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
Cantor Fitzgerald
Ross Osborn
5%downside
$3.3
Neutral
Reiterated
10 Apr 2024
Cantor Fitzgerald
Ross Osborn
5%downside
$3.3
Neutral
Maintained
1 Apr 2024

Financial journalist opinion

Based on 4 articles about AWH published over the past 30 days